reast cancer is the most common malignancy affecting women and results in the second highest female cancer mortality rate. Effective treatments have significantly prolonged survival.
survival. However, radiation may induce exuberant scar formation. In light of increased patient survival, physicians now face the daunting task of managing unintended adverse effects associated with cancer treatments.
Over 80,000 women in the United States chose implant-based breast reconstruction during 2014. 2 A sequela of implant placement is the formation of a capsular scar composed of myofibroblasts embedded in a matrix of collagen, fibronectin, and glycosaminoglycans. Myofibroblasts are key effector cells in scar tissue formation and are characterized by α-smooth muscle actin expression. [3] [4] [5] When the scarring process persists unabated, patients develop capsular contracture, a pathologic condition marked by shrinkage of the capsule, resulting in pain, breast disfigurement, a need for revision surgery, and, ultimately, possible reconstructive failure with implant loss. 6 Ionizing radiation, although beneficial in eliminating residual cancer cells, can exacerbate the scar response, resulting in increased rates of capsular contracture. [7] [8] [9] [10] [11] [12] [13] [14] Ionizing radiation compounds the body's natural scarring inclination and increases the incidence of severe capsular contracture from 1.3 percent to 30 percent of nonirradiated reconstruction patients, and from 32 percent to 73 percent of irradiated reconstruction patients. 6 The development of radiation-induced hyperactive scar formation often necessitates surgical mammaplasty revision, straining the health care system, and subjecting patients to further morbidity and mortality. 9, 11 There are no effective strategies for preventing or treating radiation-induced scarring in breast tissue, and important knowledge gaps remain regarding the specific mechanism underlying this phenomenon. [15] [16] [17] Fibroblasts, sentinel cells that can form many effector cell types, constitute a heterogeneous population that can be characterized based on their expression of the membrane-anchored protein Thy1 (CD90). [18] [19] [20] [21] Thy1 has been suggested as a potential marker for predicting myofibroblastic differentiation following exposure to profibrotic stimuli. 18, 21, 22 Fibroblasts that lack surface expression of Thy1 cannot differentiate to myofibroblasts, even under profibrotic stimulation. 21 Conversely, fibroblasts that express high levels of Thy1 can be induced to differentiate into contractile myofibroblasts. 4, 21, 23 We hypothesize that ionizing radiation increases Thy1 expression, resulting in increased myofibroblast differentiation and resultant capsular contracture.
PATIENTS AND METHODS

Biopsy Tissue
Deidentified tissue was obtained from patients undergoing implant-based breast reconstruction revision operations for any reason, including scar contracture, implant exchange, or aesthetic revision, and was frozen at −80° C. A total of 26 samples were collected, nine of which were from irradiated breasts and 17 of which were from nonirradiated breasts. All samples were handled with proper authorization from the University of Rochester Institutional Review Board. Tissue was thawed, mechanically minced, and incubated on ice in lysis buffer [60 mM Tris, pH 6.8, 2% sodium dodecyl sulfate, and protease inhibitor (Sigma, St. Louis, Mo.)] for 30 minutes. The resulting mixtures were sonicated (Vibra Cell; Sonics & Materials, Inc., Danbury, Conn.), and the supernatant was stored at −80°C.
Immunohistochemistry of Capsular Tissue
Paraffin-embedded, formalin-fixed capsular tissue was deparaffinized and treated with Universal antigen unmasking buffer following the manufacturer's instructions (R&D Systems, Minneapolis, Minn.). Tissue sections were blocked and probed using sheep anti-Thy1 polyclonal antibody (R&D Systems) at 2.0 μg/ml overnight at 4°C. Anti-sheep horseradish peroxidase-3,3′-diaminobenzidine staining kit (R&D Systems) was used following the manufacturer's protocol, and slides were counterstained with hematoxylin.
Real-Time Quantitative Polymerase Chain Reaction, Western Blotting, and Collagen Slot Blot
Capsular fibroblasts were lysed and passed through a 27-gauge needle to shear genomic DNA. RNA was isolated using the RNeasy Mini kit (Qiagen, Valencia, Calif.) according to the manufacturer's protocol. RNA concentration was measured and analyzed by quantitative polymerase chain reaction using methods and primers described previously. 24, 25 Western and collagen slot blots were performed as described previously using rabbit anti-β-tubulin (Cell Signaling Technology, Inc., Danvers, Mass.), rabbit anti-Thy1 (9798; Cell Signaling Technology), mouse anti-α-smooth muscle actin (A2547; Sigma), and goat anti-collagen 1 (8783; Santa Cruz Biotechnology, Dallas, Texas).
24,25
Cell Culture
Primary fibroblast strains, each isolated from a different individual, were explanted from breast Plastic and Reconstructive Surgery • August 2017 skin and periimplant capsular tissue samples. Tissue was minced and fibroblasts were grown and characterized as described previously. 26 Capsular fibroblasts were seeded onto six-well plates and, at 80% confluence, were serum starved (Minimal Essential Medium weight/0.05% fetal bovine serum) for 48 hours, changed to fresh media (0.05% fetal bovine serum), and treated with 2.5 ng/ml transforming growth factor (TGF)-β (R&D Systems) and/or 100 to 250 nM salinomycin.
Transduction-Mediated Thy1 Knockdown
Capsular fibroblasts were seeded onto six-well plates at a density of 50 percent and then transduced with pGIPZ shControl or pGIPZ shThy1 lentiviral particles (Open Biosystems, Lafayette, Col.) with a multiplicity of infection of 10. Cells were selected for stable integration of transgene expression in 2 μg/ml puromycin. Validation of Thy1 knockdown was confirmed by Western blot analysis.
Immunofluorescence
Capsular fibroblasts on six-well culture dishes were washed with phosphate-buffered saline and fixed with 2% paraformaldehyde for 10 minutes. Cells were rinsed in phosphate-buffered saline, and then permeabilized and blocked with 0.25% Triton-X 100, 1% bovine serum antigen in phosphate-buffered saline for an additional 30 minutes. Cells were washed and incubated with anti-Thy1 (Brilliant Violet 421; BioLegend, San Diego, Calif.), phalloidin (Alexa Fluor 594; Thermo Fisher Scientific, Waltham, Mass.), and the nucleic acid counterstain Sytox Green (Thermo Fisher) for 30 minutes. Cells were washed twice and visualized on a ZOE Imager (Bio-Rad Laboratories, Hercules, Calif.).
Flow Cytometry
Cells were collected by trypsinization, washed in phosphate-buffered saline, and then blocked with 5% normal mouse serum. Cells were incubated with anti-Thy1-phycoerythrin conjugated antibody (BD Biosciences, San Jose, Calif.) and analyzed on a FACS Canto II flow cytometer (BD Biosciences).
Statistical Analysis
Data were analyzed using GraphPad Prism (GraphPad Software, Inc., San Diego, Calif.) using the t test, with one-way and two-way analyses of variance with Sidak correction for multiple comparisons. Values of p < 0.05 were considered significant.
RESULTS
Histologic Analysis of Human Breast Tissue
The differentiation of fibroblasts into myofibroblasts with subsequent overproduction of extracellular matrix is the hallmark of fibrotic abnormalities. 4, 5 To characterize the fibroblasts that contribute to breast implant capsules, we obtained deidentified biopsy samples from both irradiated (n = 9) and nonirradiated (n = 17) breasts of women undergoing surgery following implant-based breast reconstruction (Fig. 1, left) .
Histologically, capsular contracture is marked by a hyperproliferative cellular zone composed of fibroblasts and myofibroblasts that manufacture collagen and other matrix proteins that form the capsule ( Fig. 1, right) . 27 The histopathology of periimplant capsule is shown in the representative photomicrographs in Supplemental 
Thy1 Expression Is Greatest in Irradiated Capsule
We next quantified and compared several key mRNAs from capsule scar and normal skin samples. There was not a significant difference in the amount of ACTA2 or COL1A mRNA in capsule tissue compared to normal skin despite the pathologic scar tissue present in the capsule. However, Thy1 mRNA in both nonirradiated and irradiated capsule tissue were 5.3-and 18.7-fold increased over levels from normal skin (Fig. 2, left) . Further analysis confirmed the significance of the 3.7-fold increase in Thy1 in the irradiated versus nonirradiated capsules.
Evaluation of Thy1 protein levels by Western blotting showed that irradiated capsular lysates were over 100-fold greater than normal skin and 2.8-fold above nonirradiated capsule samples (Fig. 2, right) . The mean value for nonirradiated capsule had an approximately 35-fold increase above normal skin (Fig. 2, right) . Next, we had the opportunity to compare Thy1 levels from capsule tissue taken from the same patient where one side was irradiated and the other side was not (Fig. 3) . In this patient-matched analysis, irradiated tissue had 5.1-fold greater Thy1 mRNA and 2.8-fold (Fig. 3) .
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Explanted Human Capsular Fibroblasts Express Thy1
To test capsular fibroblasts in vitro, cells were explanted from biopsy samples. We observed that fibroblasts from nonirradiated capsule could be grown, trypsinized, and plated to expand the cultures up to at least 12 serial passages; however, irradiated cells assumed a flattened, spiculated morphology, indicative of myofibroblast differentiation, 28, 29 and failed to proliferate following explantation from the primary tissue. Growth of irradiated cells was resistant to stimulation, either with fetal bovine serum or with the addition of specialized fibroblast growth medium. Irradiated capsule tissue fibroblasts may be more terminally differentiated into myofibroblasts, thus blocking further proliferation and subsequent expansion of the cultures. By contrast, the nonirradiated fibroblasts appeared as a heterogeneous population of cells, spanning the phenotypic spectrum from elongated, rounded fibroblasts to flatter, spiculated cells (Fig. 4, left) . This morphology was maintained through serial passages, and Western blot analysis (Fig. 4, right) and flow cytometry (data not shown) confirmed preserved expression of Thy1 protein. Because of poor fibroblast growth from irradiated tissue, these cells could not be expanded; however, enough cells were initially grown to compare basal levels of Thy1. When compared against nonirradiated capsule fibroblasts in vitro, irradiated fibroblasts demonstrated a 5.3-fold increase in Thy1 (Fig. 5, right) (p = 0.04).
Reduction of Thy1 Expression Using Thy1 ShortHairpin RNA Decreases α-Smooth Muscle Actin and Collagen Levels in Capsular Fibroblasts
To determine whether expression of Thy1 was important for capsular fibroblast morphology, we used short-hairpin RNA to deplete cells of Thy1. Thy1 short-hairpin RNA-treated cells exhibited a 75 percent reduction in Thy1 expression and α-smooth muscle actin, and collagen 1A levels also dropped by 48 percent and 58 percent, respectively, compared with control fibroblasts (Fig. 5, left) . These findings were confirmed by Western blot analysis (Fig. 5,  right) . Immunofluorescent images also show the reduction of Thy1 expression and a decrease in parallel protein structure and organization in the shorthairpin Thy1 fibroblasts (Fig. 6 ). This structural change correlates with a greater proportion of cells assuming a rounded appearance with elongated stroma consistent with undifferentiated fibroblasts. By contrast, control cells appeared morphologically comparable to nontransduced cells, with a mixture of flattened and rounded fibroblasts. 
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Salinomycin Reduces Thy1 Expression in Human Capsular Fibroblasts
Having shown that fibroblasts maintained Thy1 expression following explantation, we next sought to mimic tissue insult by means of in vitro activation of the scarring pathway. TGF-β, a fibrotic stimulus, induced a 4-fold increase in α-smooth muscle actin, and a roughly 50 percent increase in soluble collagen production (Fig. 7, above, right  and center) . In a previous screen for antiscarring drugs, we discovered the antiscarring effects of an antibiotic, salinomycin. 25 However, it is unknown whether salinomycin affects Thy1 expression to mitigate myofibroblast formation. When treated with salinomycin, fibroblasts experienced a threefold reduction in Thy1 expression; also, α-smooth muscle actin was decreased by 65 percent and collagen was decreased by 92 percent (Fig. 7, above  and center) . Even in the presence of TGF-β, salinomycin dampened myofibroblast formation in human capsular fibroblasts, reducing α-smooth muscle actin by 86 percent and collagen 1A by 74 percent below basal, untreated levels (Fig. 7,  above, right and center) . Excitingly, salinomycin not only negated the profibrotic effects of TGF-β, but this decrease in capsular fibroblast protein production was associated with a 76 percent reduction in Thy1 (Fig. 7, above) . These findings were confirmed by Western blot analysis (Fig. 7, below) .
DISCUSSION
This study demonstrates that periimplant capsules express significantly higher Thy1 levels compared with normal skin samples. Furthermore, irradiated capsule showed higher levels of Thy1 mRNA and protein compared with nonirradiated capsule. Increased Thy1 may relate to a fibroblast cell population or population subset that is more responsive to chemoattraction and activation by profibrotic cytokines. Fibroblasts that Fig. 6 . Thy1 depletion affects cellular morphology. Qualitative changes observed in short-hairpin Thy1 fibroblasts (left) compared with control fibroblasts (right) include elongated soma with fewer cytoplasmic projections, rounded shape, and greater in vitro cell density. Cells were stained for DNA (green) using Sytox Green, filamentous actin (red) using phallodin-AF594, and Thy1 (blue) using anti-Thy1 antibody conjugated to BV421.
highly express Thy1 are present and/or recruited to the periimplant site to respond to the inflammatory signaling caused by tissue injury that leads to wound healing and scarring. Normal skin was chosen as the control tissue, as breast parenchyma is composed largely of adipocytes, which likely arise from Thy1-negative fibroblasts, and therefore do not possess the same scarring potential. 20, 30 Fig. 7. Salinomycin reduces basal and TGF-β-induced myofibroblast formation. Fibroblasts increased production of α-smooth muscle actin (αSMA) by 334 percent and collagen 1A production by 48 percent when exposed to TGF-β. Treatment with salinomycin (SNC) not only reduces basal expression of (above, left) Thy1, (above, right) α-smooth muscle actin, and (center) collagen 1A, but also prevents myofibroblast induction by TGF-β. (Below) Thy1 and α-smooth muscle actin levels normalized to β-tubulin. Collagen was quantified by means of slot blot based on loading equal culture supernatant volume. #p < 0.05 compared to vehicle; **p < 0.01; ****p < 0.0001.
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We further divided pericapsular tissue into biopsy specimens taken from breasts that had previously undergone radiation therapy and those from radiation-naive breasts. When compared, radiation-treated tissue showed higher Thy1 mRNA and protein levels. Given the scope of our current study, and the fact that patient deidentification precluded us from doing so, we chose not to pursue correlation of Thy1 to factors such as time from implant placement, time from radiation treatment, Baker stage, or other variables. However, the acquisition of bilateral samples from four women after unilateral radiation treatment enabled paired comparisons using a patient's own nonirradiated tissue as an internal control. This helped to control for the large degree of interhuman variability, and the time from surgery to tissue harvest. These novel results show that a history of radiation treatment correlates with increased Thy1, indicating that radiotherapy up-regulates locoregional protein expression. This finding is consistent with published data showing Thy1 upregulation following inflammatory stimulus. 18, 22, 31 The degree to which Thy1 is expressed in a given tissue may then correlate with the propensity of fibroblasts in that tissue to differentiate to myofibroblasts and increase their scar production. Although our data show that radiation leads to increased expression of Thy1 in capsular scars, it is unknown whether Thy1 expression would differ based on capsules that form because of other insults such as microbial biofilm, heme deposits, and others. Future work looking at capsules that form from other causes, and Thy1 kinetics in capsular tissue after irradiation, are required.
Although the full extent of its physiologic role remains enigmatic, Thy1 does appear to play a role in fibroblast differentiation. 20, 21 We sought to isolate and reduce the Thy1 levels on capsular fibroblasts to determine downstream effects on collagen and α-smooth muscle actin production. Thy1 reduction translated into a concomitant reduction in both α-smooth muscle actin and collagen without any additional treatments, indicating that Thy1 expression is important in determining a cell's basal scar production ability. Furthermore, Thy1 reduction also altered the cellular phenotype of capsular fibroblasts. The differentiation of fibroblasts to myofibroblasts with increased matrix deposition and the generation of contractile forces in vivo requires multiple signaling mechanisms at the site of tissue injury. [32] [33] [34] Current understanding implicates a central role for TGF-β in both the inflammatory and fibrotic phases of capsular scar development. 35, 36 Acute injury at the site as a result of surgery, infection, radiation therapy, mechanical stress, or other factors causes TGF-β release in conjunction with dense granule release from platelets. 37, 38 In this setting, the local TGF-β acts as a chemokine for monocyte recruitment and eventual differentiation into macrophages, thereby priming the chronic inflammatory phase. 39, 40 During this phase, macrophages continue production of TGF-β, which signals migration of either resident or circulating fibrocytes to the site of injury, wherein they produce the lattice of collagen, fibronectin, and α-smooth muscle actin that will eventually form a mature scar. 36 Having established TGF-β-induced production of α-smooth muscle actin and collagen, we next sought to determine the effects of salinomycin on both untreated and induced cells. Salinomycin successfully reduced α-smooth muscle actin and collagen production as previously shown in other fibroblasts. 25 Excitingly, in this study, we show for the first time that salinomycin reduced expression of Thy1 in human capsular fibroblasts. Interestingly, a greater reduction in scar matrix protein production was seen with salinomycin treatment than with Thy1 reduction by means of lentiviral transduction alone, and likely occurs because of the effect of salinomycin on both Thy1 expression and its influence on the TGF-β-induced cellular response. 25 Similar to Thy1 reduction by means of lentiviral vector, fibroblasts treated with salinomycin also exhibited morphologic changes. This may, in fact, represent a phenotypic reversal of a proportion of total cells from a myofibroblast state back to fibroblasts, as loss of Thy1 prevents these cells from being able to maintain their myofibroblast differentiation. The phenotypic change in these cells persisted despite co-culture with TGF-β, consistent with previous work showing that Thy1-negative fibroblasts are resistant to profibrotic influence. 21 Thus, salinomycin appears to have a dual mechanism of scar mitigation, both by (1) decreasing constitutive Thy1 expression and preventing associated myofibroblast differentiation, and (2) reducing the inherent cellular response to TGF-β.
The ability of salinomycin to blunt capsular myofibroblast formation reveals that future studies testing salinomycin efficacy in vivo are warranted. To treat capsular contracture, many delivery methods of salinomycin or other promising drug candidates are possible. Systemic routes such as oral dosing, intravenous injections, or localized capsule coating or site injections could be considered. We recently reported coating a temporary wound dressing with salinomycin and demonstrated dramatic reduction in myofibroblast formation. 41 Salinomycin is an antibiotic and can kill many Gram-positive bacteria; thus, an additional potential benefit could be its antimicrobial action if used in vivo. 25 Furthermore, salinomycin is also being tested as a chemotherapy for breast cancer through injection and has so far proved promising. [42] [43] [44] Future studies aimed at elucidating the best delivery methods for blocking capsular contracture are needed.
CONCLUSIONS
Increased Thy1 in fibroblasts from irradiated breast capsules suggests a possible mechanism for the increased incidence of capsular contracture in radiotherapy-treated patients. Irradiated capsule showed higher Thy1 mRNA and protein levels, but in vivo blockade using salinomycin resulted in reduced scar component production and a phenotypic disruption of myofibroblast transformation. Given our new understanding of Thy1's role in myofibroblast differentiation and scar production in capsular contracture, Thy1-targeting therapies such as salinomycin could potentially reduce capsular scarring following irradiation or inhibit its formation if preempted appropriately. 
